EPA has been shown to have beneficial effects in HFD-induced liver steatosis and decline in energy metabolism (Echeverria et al., 2019), possibly through its interaction with PPARα (Sugiyama et al., 2008). The gene discussed is PPARA; the disease is fatty liver disease.